Enhanced ADAM17 expression is associated with cardiac remodeling in rats with acute myocardial infarction

Life Sciences

Volumn 151, Issue , 2016, Pages 61-69

  Zheng, Dong You ^a   Zhao, Juan ^a   Yang, Jie Mei ^a   Wang, Miao ^a   Zhang, Xing Tong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

A disintegrin and metalloproteinase 17; Left ventricle; Myocardial infarction; Myocardial remodeling; Tissue inhibitor of metalloproteinase 3; Tumor necrosis factor

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE 17 PROTEIN; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADAM17 PROTEIN, RAT; C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; MALE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; RAT; SURVIVAL RATE; SYSTOLIC DYSFUNCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; GENETICS; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MITOCHONDRION; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY; WISTAR RAT;

ADAM17 PROTEIN; ANIMALS; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY; HYPERTROPHY, LEFT VENTRICULAR; MALE; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 84960353942     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.02.097     Document Type: Article

References (54)

1. A. Aminlari, M. Jazayeri Shooshtari, and A.R. Bakhshandeh Association of cardiac rehabilitation with improvement in high sensitive C-reactive protein post-myocardial infarction Iran Red Crescent Med. J. 14 2012 49 50
2. W.S. Bradham, B. Bozkurt, H. Gunasinghe, D. Mann, and F.G. Spinale Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective Cardiovasc. Res. 53 2002 822 830
3. W.S. Bradham, G. Moe, K.A. Wendt, A.A. Scott, A. Konig, M. Romanova, and et al. TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling Am. J. Physiol. Heart Circ. Physiol. 282 2002 H1288 H1295
4. D. Carnevale, G. Cifelli, G. Mascio, M. Madonna, M. Sbroggio, C. Perrino, and et al. Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-alpha-converting enzyme axis: crucial role for adaptive cardiac remodeling during cardiac pressure overload Circulation 124 2011 1337 1350
5. R.B. Driesen, F.K. Verheyen, P. Dijkstra, F. Thone, J.P. Cleutjens, M.H. Lenders, and et al. Structural remodelling of cardiomyocytes in the border zone of infarcted rabbit heart Mol. Cell. Biochem. 302 2007 225 232
6. J.G. Dumesnil, D. Dion, K. Yvorchuk, R.A. Davies, and K. Chan A new, simple and accurate method for determining ejection fraction by Doppler echocardiography Can. J. Cardiol. 11 1995 1007 1014
7. D. Fan, A. Takawale, M. Shen, W. Wang, X. Wang, R. Basu, and et al. Cardiomyocyte A disintegrin and metalloproteinase 17 (ADAM17) is essential in post-myocardial infarction repair by regulating angiogenesis Circ. Heart Fail. 8 5 2015 970 979
8. A.M. Fara Ventricular remodeling following myocardial infarction: a description of the pathologic process, current investigation, and suggested therapy Crit. Care Nurs. Clin. North Am. 4 1992 325 337
9. P.W. Fedak, C.S. Moravec, P.M. McCarthy, S.M. Altamentova, A.P. Wong, M. Skrtic, and et al. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy Circulation 113 2006 238 245
10. M. Fertin, A. Bauters, F. Pinet, and C. Bauters Circulating levels of soluble Fas ligand and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study) J. Cardiol. 60 2012 93 97
11. M.C. Fishbein, D. Maclean, and P.R. Maroko Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution Am. J. Pathol. 90 1978 57 70
12. S.M. Ghaderian, R. Akbarzadeh Najar, and A.S. Tabatabaei Panah Tumor necrosis factor-alpha: investigation of gene polymorphism and regulation of TACE-TNF-alpha system in patients with acute myocardial infarction Mol. Biol. Rep. 38 2011 4971 4977
13. E.C. Goldsmith, A.D. Bradshaw, and F.G. Spinale Cellular mechanisms of tissue fibrosis. 2. Contributory pathwaysleading to myocardial fibrosis: moving beyond collagen expression Am. J. Physiol. Cell Physiol. 304 2013 C393 C402
14. G. Heba, T. Krzeminski, M. Porc, J. Grzyb, and A. Dembinska-Kiec Relation between expression of TNF alpha, iNOS, VEGF mRNA and development of heart failure after experimental myocardial infarction in rats J. Physiol. Pharmacol. 52 2001 39 52
15. M.P. Hudson, P.W. Armstrong, W. Ruzyllo, J. Brum, L. Cusmano, P. Krzeski, and et al. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial J. Am. Coll. Cardiol. 48 2006 15 20
16. M. Iglarz, A. Bossu, D. Wanner, C. Bortolamiol, M. Rey, P. Hess, and et al. Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension Life Sci. 118 2014 333 339
17. T.N. Johns, and B.J. Olson Experimental myocardial infarction. I. A method of coronary occlusion in small animals Ann. Surg. 140 1954 675 682
18. M. Kashiwagi, A. Tanaka, H. Kitabata, H. Tsujioka, H. Matsumoto, Y. Arita, and et al. Relationship between coronary arterial remodeling, fibrous cap thickness and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome Circ. J. 73 2009 1291 1295
19. Z. Kassiri, G.Y. Oudit, O. Sanchez, F. Dawood, F.F. Mohammed, R.K. Nuttall, and et al. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice Circ. Res. 97 2005 380 390
20. P. Kleinbongard, R. Schulz, and G. Heusch TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure Heart Fail. Rev. 16 2011 49 69
21. M. Kveiborg, R. Instrell, C. Rowlands, M. Howell, and P.J. Parker PKCalpha and PKCdelta regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways PLoS One 6 2011 e17168
22. H.I. Kwak, E.A. Mendoza, and K.J. Bayless ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices Matrix Biol. 28 2009 470 479
23. N. Lamblin, A. Bauters, M. Fertin, P. de Groote, F. Pinet, and C. Bauters Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study) Eur. J. Heart Fail. 13 2011 1314 1322
24. Y.Y. Li, Y.Q. Feng, T. Kadokami, C.F. McTiernan, R. Draviam, S.C. Watkins, and et al. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy Proc. Natl. Acad. Sci. U. S. A. 97 2000 12746 12751
25. X. Liu, A.S. Pachori, C.A. Ward, J.P. Davis, M. Gnecchi, D. Kong, and et al. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function FASEB J. 20 2006 207 216
26. D.M. Lloyd-Jones, K. Liu, L. Tian, and P. Greenland Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease Ann. Intern. Med. 145 2006 35 42
27. J.L. Lucitti, J.K. Mackey, J.C. Morrison, J.J. Haigh, R.H. Adams, and J.E. Faber Formation of the collateral circulation is regulated by vascular endothelial growth factor-A and a disintegrin and metalloprotease family members 10 and 17 Circ. Res. 111 2012 1539 1550
28. A.K. Madiraju, D.M. Erion, Y. Rahimi, X.M. Zhang, D.T. Braddock, R.A. Albright, and et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase Nature 510 2014 542 546
29. M. Mahmoodi, S. Sahebjam, D. Smookler, R. Khokha, and J.S. Mort Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis Am. J. Pathol. 166 2005 1733 1740
30. C.G. Manole, V. Cismasiu, M. Gherghiceanu, and L.M. Popescu Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis J. Cell. Mol. Med. 15 2011 2284 2296
31. A.M. Manso, L. Elsherif, S.M. Kang, and R.S. Ross Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling Cardiovasc. Res. 69 2006 574 584
32. R. Menghini, L. Fiorentino, V. Casagrande, R. Lauro, and M. Federici The role of ADAM17 in metabolic inflammation Atherosclerosis 228 2013 12 17
33. R.D. Nadadur, S. Umar, G. Wong, M. Eghbali, A. Iorga, H. Matori, and et al. Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension J. Appl. Physiol. (1985) 113 2012 149 158
34. M.A. Pfeffer, J.M. Pfeffer, M.C. Fishbein, P.J. Fletcher, J. Spadaro, R.A. Kloner, and et al. Myocardial infarct size and ventricular function in rats Circ. Res. 44 1979 503 512
35. J.H. Qi, Q. Ebrahem, N. Moore, G. Murphy, L. Claesson-Welsh, M. Bond, and et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Nat. Med. 9 2003 407 415
36. H. Rashidinejad, S.M. Hosseini, M. Moazenzadeh, B.S. Azimzadeh, F. Mirzaeipour, K. Fakhreddini, and et al. Relationship between serum level of high-sensitive C-reactive protein and extension of myocardial involvement in patients with acute myocardial infarction Rom. J. Intern. Med. 50 2012 211 215
37. S. Rose-John ADAM17, shedding, TACE as therapeutic targets Pharmacol. Res. 71 2013 19 22
38. M. Satoh, Y. Ishikawa, T. Itoh, Y. Minami, Y. Takahashi, and M. Nakamura The expression of TNF-alpha converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction Eur. J. Clin. Investig. 38 2008 97 105
39. S. Rizza, M. Copetti, M. Cardellini, R. Menghini, C. Pecchioli, A. Luzi, and et al. A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis Atherosclerosis 239 2 2015 459 464
40. R. Schulz, and G. Heusch Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction? Circulation 119 2009 1355 1357
41. J. Schwarz, S. Schmidt, O. Will, T. Koudelka, K. Kohler, M. Boss, and et al. Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor alpha ectodomain shedding J. Biol. Chem. 289 2014 3080 3093
42. W. Shi, H. Chen, J. Sun, S. Buckley, J. Zhao, K.D. Anderson, and et al. TACE is required for fetal murine cardiac development and modeling Dev. Biol. 261 2003 371 380
43. Y. Shimoda, M. Satoh, M. Nakamura, T. Akatsu, and K. Hiramori Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction Clin. Sci. (Lond.) 108 2005 339 347
44. R.S. Smith Jr., J. Agata, C.F. Xia, L. Chao, and J. Chao Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction Life Sci. 76 2005 2457 2471
45. M. Sun, F. Dawood, W.H. Wen, M. Chen, I. Dixon, L.A. Kirshenbaum, and et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction Circulation 110 2004 3221 3228
46. J. Taieb, C. Delarche, F. Ethuin, S. Selloum, T. Poynard, M.A. Gougerot-Pocidalo, and et al. Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophils J. Leukoc. Biol. 72 2002 1142 1147
47. X. Wang, T. Oka, F.L. Chow, S.B. Cooper, J. Odenbach, G.D. Lopaschuk, and et al. Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis Hypertension 54 2009 575 582
48. P. Xu, J. Liu, M. Sakaki-Yumoto, and R. Derynck TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association Sci. Signal. 5 2012 ra34
49. Z.R. Yousef, S.R. Redwood, and M.S. Marber Postinfarction left ventricular remodeling: a pathophysiological and therapeutic review Cardiovasc. Drugs Ther. 14 2000 243 252
50. J. Zhao, X.F. Qu, C.Y. Zhao, F.L. Cao, T. Zhou, W.M. Li, and et al. Effects of metoprolol treatment on a disintegrin metalloproteinase expression and extracellular matrix remodeling after myocardial infarction in rats Chin. Med. J. 120 2007 1549 1552
51. S. Düsterhöft, M. Michalek, F. Kordowski, M. Oldefest, A. Sommer, and J. Röseler Extracellular juxtamembrane segment of ADAM17 interacts with membranes and is essential for its shedding activity Biochemistry 54 2015 5791 5801
52. J. Palazuelos, M. Klingener, E.W. Raines, H.C. Crawford, and A. Aguirre Oligodendrocyte regeneration and CNS remyelination require TACE/ADAM17 J. Neurosci. 35 2015 12241 12247
53. G.G. Vietta, M.E. Andrades, R. Dall'alba, S.I. Schneider, L.M. Frick, U. Matte, and et al. Early use of cardiac troponin-I and echocardiography imaging for prediction of myocardial infarction size in Wistar rats Life Sci. 93 2013 139 144
54. L.E. Juárez-Orozco, M.K. Szymanski, H.L. Hillege, S. Kruizinga, W. Noordzij, and M. Koole Imaging of cardiac and renal perfusion in a rat model with 13N-NH3 micro-PET Int. J. Cardiovasc. Imaging. 31 2015 213 219